Literature DB >> 31053235

Temporal evolution of myeloperoxidase and galectin 3 during 1 year after acute coronary syndrome admission.

Maxime M Vroegindewey1, Victor J van den Berg2, Elke Bouwens1, K Martijn Akkerhuis1, Rohit M Oemrawsingh3, Folkert W Asselbergs4, Timo Lenderink5, Pim van der Harst6, Eelco Ronner7, Victor A W M Umans8, Isabella Kardys1, Eric Boersma9.   

Abstract

Prior studies reported that Myeloperoxidase and Galectin-3, which are biomarkers of coronary plaque vulnerability, are elevated in acute coronary syndrome (ACS) patients. We studied the temporal evolution of these biomarkers early after ACS admission and prior to a recurrent ACS event during 1 year follow-up.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31053235     DOI： 10.1016/j.ahj.2019.02.016

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


  1 in total

1.  Details on high frequency blood collection, data analysis, available material and patient characteristics in BIOMArCS.

Authors:  Eric Boersma; Maxime M Vroegindewey; Victor J van den Berg; Folkert W Asselbergs; Pim van der Harst; Bas Kietselaer; Timo Lenderink; Anton J Oude Ophuis; Victor A W M Umans; Robbert J de Winter; Rohit M Oemrawsingh; K Martijn Akkerhuis
Journal:  Data Brief       Date:  2019-11-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.